Lobbying Relationship

Client

Ambio

More records

Lobbying firm

Quadripoint Strategies LLC

More records

  • FDA regulation of generic insulin and peptide-based insulin products

Duration: to

General Issues: Pharmacy

Spending: about $47,250 (But it's complicated. Here's why.)

Agencies lobbied since 2019: U.S. Senate, White House Office, Food & Drug Administration (FDA), Office of the Vice President of the United States, House of Representatives, Centers For Medicare and Medicaid Services (CMS)

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
David Crane Senior Policy Advisor - Senate Majority Leader/Republican Leader Trent Lott, Professional Staff - Senate Commerce Committee - Chairman John McCain, Leg Assistant, Leg Director, Senator Dan Coats Senior Policy Advisor, Majority Leader/Republican Leader Trent Lott, Professional Staff, Senate Commerce Committee, Chairman John McCain, LA/LD Senator Dan Coats

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Termination
Amendment
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page